Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Consider growth hormone peptides (Ipamorelin + CJC-1295) if systemic support desired though effects slower manifesting
Administered by Dr
Option Cagrilintide Evidence for the added compound Human Phase 2 data alone and Phase 3 data with semaglutide Evidence for the retatrutide combination None identified Option Tesamorelin Evidence for the added compound Randomized trials and an FDA-approved narrow indication Evidence for the retatrutide combination None identified Option CJC-1295 + ipamorelin Evidence for the added compound Small human studies showing GH or IGF-1 response Evidence for the retatrutide combination None identified Option MOTS-C Evidence for the added compound Human observational biology plus mostly preclinical treatment research Evidence for the retatrutide combination None identified This ranking describes research depth
Clinically, BPC-157 is best suited for acute and subacute soft-tissue injuries, including tendon, ligament, muscle, fascia, and periarticular soft-tissue problems
Researchers commonly investigate: collagen pathways
US$ 22.70
US$ 24.45
US$ 25.36
US$ 29.59
US$ 24.41
